Found: 51
Select item for more details and to access through your institution.
Transient Neonatal Myelosuppression after Fetal Exposure to Maternal Chemotherapy.
- Published in:
- Neonatology (16617800), 2008, v. 95, n. 1, p. 80
- By:
- Publication type:
- Article
Clinical Outcomes of 217 Patients with Acute Erythroleukemia According to Treatment Type and Line: A Retrospective Multinational Study.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 4, p. 837, doi. 10.3390/ijms18040837
- By:
- Publication type:
- Article
Clinical Implication of Multi-Parameter Flow Cytometry in Myelodysplastic Syndromes.
- Published in:
- Pathobiology, 2019, v. 86, n. 1, p. 14, doi. 10.1159/000490727
- By:
- Publication type:
- Article
Clinical Implication of Multi-Parameter Flow Cytometry in Myelodysplastic Syndromes.
- Published in:
- Pathobiology, 2018, v. 85, n. 5/6, p. 274, doi. 10.1159/000490727
- By:
- Publication type:
- Article
Seizures in a Patient with Disseminated Testicular Cancer due to Cisplatin-induced Hypomagnesamia.
- Published in:
- Acta Oncologica, 2000, v. 39, n. 2, doi. 10.1080/028418600430851
- By:
- Publication type:
- Article
ATG versus PTCy in matched unrelated donor haematopoietic stem cell transplantations with non‐myeloablative conditioning.
- Published in:
- British Journal of Haematology, 2023, v. 203, n. 3, p. 439, doi. 10.1111/bjh.19031
- By:
- Publication type:
- Article
The wider perspective: twenty years of clinical trials in myelodysplastic syndromes.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 2, p. 329, doi. 10.1111/bjh.17892
- By:
- Publication type:
- Article
Human Bone Marrow-Derived Myeloid Dendritic Cells Show an Immature Transcriptional and Functional Profile Compared to Their Peripheral Blood Counterparts and Separate from Slan+ Non-Classical Monocytes.
- Published in:
- Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.01619
- By:
- Publication type:
- Article
A Human Cell Line Model for Interferon-α Driven Dendritic Cell Differentiation.
- Published in:
- PLoS ONE, 2015, v. 10, n. 8, p. 1, doi. 10.1371/journal.pone.0135219
- By:
- Publication type:
- Article
Engagement of SIRPα Inhibits Growth and Induces Programmed Cell Death in Acute Myeloid Leukemia Cells.
- Published in:
- PLoS ONE, 2013, v. 8, n. 1, p. 1, doi. 10.1371/journal.pone.0052143
- By:
- Publication type:
- Article
Promiscuous Binding of Invariant Chain-Derived CLIP Peptide to Distinct HLA-I Molecules Revealed in Leukemic Cells.
- Published in:
- PLoS ONE, 2012, v. 7, n. 4, p. 1, doi. 10.1371/journal.pone.0034649
- By:
- Publication type:
- Article
Monitoring treatment with 5-Azacitidine by flow cytometry predicts duration of hematological response in patients with myelodysplastic syndrome.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 7, p. 1711, doi. 10.1007/s00277-021-04411-4
- By:
- Publication type:
- Article
A novel allogeneic off-the-shelf dendritic cell vaccine for post-remission treatment of elderly patients with acute myeloid leukemia.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 10, p. 1505, doi. 10.1007/s00262-018-2198-9
- By:
- Publication type:
- Article
Alternative Ii-independent antigen-processing pathway in leukemic blasts involves TAP-dependent peptide loading of HLA class II complexes.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 12, p. 1825, doi. 10.1007/s00262-010-0908-z
- By:
- Publication type:
- Article
Rapid generation of antigen-presenting cells from leukaemic blasts in acute myeloid leukaemia.
- Published in:
- 2003
- By:
- Publication type:
- Erratum
Serum-free generation of antigen presenting cells from acute myeloid leukaemic blasts for active specific immunisation.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 7, p. 455, doi. 10.1007/s00262-003-0389-4
- By:
- Publication type:
- Article
Rapid generation of antigen-presenting cells from leukaemic blasts in acute myeloid leukaemia.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 1, p. 17, doi. 10.1007/s00262-002-0316-0
- By:
- Publication type:
- Article
6-Sulfo LacNAc (Slan) as a Marker for Non-classical Monocytes.
- Published in:
- Frontiers in Immunology, 2019, p. 1, doi. 10.3389/fimmu.2019.02052
- By:
- Publication type:
- Article
Glycan-Modified Apoptotic Melanoma-Derived Extracellular Vesicles as Antigen Source for Anti-Tumor Vaccination.
- Published in:
- Cancers, 2019, v. 11, n. 9, p. 1266, doi. 10.3390/cancers11091266
- By:
- Publication type:
- Article
Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome: A report of the European LeukemiaNet International MDS‐Flow Cytometry Working Group.
- Published in:
- Cytometry. Part B, 2023, v. 104, n. 1, p. 77, doi. 10.1002/cyto.b.22044
- By:
- Publication type:
- Article
ELN iMDS flow working group validation of the monocyte assay for chronic myelomonocytic leukemia diagnosis by flow cytometry.
- Published in:
- Cytometry. Part B, 2023, v. 104, n. 1, p. 66, doi. 10.1002/cyto.b.22054
- By:
- Publication type:
- Article
Characterization of myelodysplastic syndromes hematopoietic stem and progenitor cells using mass cytometry.
- Published in:
- Cytometry. Part B, 2023, v. 104, n. 2, p. 128, doi. 10.1002/cyto.b.22066
- By:
- Publication type:
- Article
Dysplasia and PNH‐type cells in bone marrow aspirates of myelodysplastic syndromes.
- Published in:
- Cytometry. Part B, 2023, v. 104, n. 2, p. 162, doi. 10.1002/cyto.b.22038
- By:
- Publication type:
- Article
Flow cytometry in the diagnosis of myelodysplastic syndromes.
- Published in:
- Cytometry. Part B, 2023, v. 104, n. 1, p. 10, doi. 10.1002/cyto.b.22103
- By:
- Publication type:
- Article
A series of case studies illustrating the role of flow cytometry in the diagnostic work‐up of myelodysplastic syndromes.
- Published in:
- Cytometry. Part B, 2023, v. 104, n. 1, p. 87, doi. 10.1002/cyto.b.22061
- By:
- Publication type:
- Article
Application of flow cytometry for myelodysplastic syndromes: Pitfalls and technical considerations.
- Published in:
- Cytometry. Part B, 2016, v. 90, n. 4, p. 358, doi. 10.1002/cyto.b.21333
- By:
- Publication type:
- Article
Absence of aberrant myeloid progenitors by flow cytometry is associated with favorable response to azacitidine in higher risk myelodysplastic syndromes.
- Published in:
- Cytometry. Part B, 2014, v. 86B, n. 3, p. 207, doi. 10.1002/cyto.b.21160
- By:
- Publication type:
- Article
A threshold of 10% for myeloperoxidase by flow cytometry is valid to classify acute leukemia of ambiguous and myeloid origin.
- Published in:
- Cytometry. Part B, 2013, v. 84B, n. 2, p. 114, doi. 10.1002/cyto.b.21072
- By:
- Publication type:
- Article
Computational flow cytometry as a diagnostic tool in suspected‐myelodysplastic syndromes.
- Published in:
- Cytometry. Part A, 2021, v. 99, n. 8, p. 814, doi. 10.1002/cyto.a.24360
- By:
- Publication type:
- Article
Management of infection prophylaxis in Dutch patients with myelodysplastic syndromes, a web‐based case vignette questionnaire: The MINDSET study.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 4, p. 381, doi. 10.1111/ejh.13820
- By:
- Publication type:
- Article
Benefits and risks of clofarabine in adult acute lymphoblastic leukemia investigated in depth by multi‐state modeling.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 9, p. 1, doi. 10.1002/cam4.6756
- By:
- Publication type:
- Article
The Effect of SF3B1 Mutation on the DNA Damage Response and Nonsense-Mediated mRNA Decay in Cancer.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.609409
- By:
- Publication type:
- Article
Imatinib mesylate in the treatment of systemic mastocytosis: a phase II trial.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Imatinib mesylate in the treatment of systemic mastocytosis.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 2, p. 345, doi. 10.1002/cncr.21996
- By:
- Publication type:
- Article
The immunoregulatory role of monocytes and thrombomodulin in myelodysplastic neoplasms.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1414102
- By:
- Publication type:
- Article
Age and sex associate with outcome in older AML and high risk MDS patients treated with 10-day decitabine.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00850-6
- By:
- Publication type:
- Article
Age and sex associate with outcome in older AML and high risk MDS patients treated with 10-day decitabine.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00850-6
- By:
- Publication type:
- Article
Management of patients with lower-risk myelodysplastic syndromes.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 12, p. 1, doi. 10.1038/s41408-022-00765-8
- By:
- Publication type:
- Article
Genomic array as compared to karyotyping in myelodysplastic syndromes in a prospective clinical trial.
- Published in:
- Genes, Chromosomes & Cancer, 2017, v. 56, n. 7, p. 524, doi. 10.1002/gcc.22455
- By:
- Publication type:
- Article
Validation of and proposals for refinements of the WHO 2016 classification for myelodysplastic syndromes.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 11, p. E631, doi. 10.1002/ajh.24867
- By:
- Publication type:
- Article
Platelet doubling after the first azacitidine cycle is a promising predictor for response in myelodysplastic syndromes (MDS), chronic myelomonocytic leukaemia (CMML) and acute myeloid leukaemia (AML) patients in the Dutch azacitidine compassionate named patient programme
- Published in:
- British Journal of Haematology, 2011, v. 155, n. 5, p. 599, doi. 10.1111/j.1365-2141.2011.08893.x
- By:
- Publication type:
- Article
Role of immune responses in the pathogenesis of low-risk MDS and high-risk MDS: implications for immunotherapy.
- Published in:
- British Journal of Haematology, 2011, v. 153, n. 5, p. 568, doi. 10.1111/j.1365-2141.2011.08683.x
- By:
- Publication type:
- Article
Review of the relevance of aberrant antigen expression by flow cytometry in myeloid neoplasms.
- Published in:
- British Journal of Haematology, 2011, v. 153, n. 4, p. 421, doi. 10.1111/j.1365-2141.2011.08595.x
- By:
- Publication type:
- Article
Detection of aberrant transcription of major histocompatibility complex class II antigen presentation genes in chronic lymphocytic leukaemia identifies HLA-DOA mRNA as a prognostic factor for survival.
- Published in:
- British Journal of Haematology, 2009, v. 145, n. 3, p. 334, doi. 10.1111/j.1365-2141.2009.07625.x
- By:
- Publication type:
- Article
The novel bispecific diabody αCD40/αCD28 strengthens leukaemic dendritic cell-induced T-cell reactivity.
- Published in:
- British Journal of Haematology, 2008, v. 142, n. 2, p. 273, doi. 10.1111/j.1365-2141.2008.06990.x
- By:
- Publication type:
- Article
The ABNL-MARRO 001 study: a phase 1–2 study of randomly allocated active myeloid target compound combinations in MDS/MPN overlap syndromes.
- Published in:
- BMC Cancer, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12885-022-10073-w
- By:
- Publication type:
- Article
The ABNL-MARRO 001 study: a phase 1-2 study of randomly allocated active myeloid target compound combinations in MDS/MPN overlap syndromes.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis.
- Published in:
- JAMA: Journal of the American Medical Association, 2014, v. 311, n. 24, p. 2490, doi. 10.1001/jama.2014.6368
- By:
- Publication type:
- Article
Increased prescription rate of anti‐infective agents after diagnosis of myelodysplastic syndromes.
- Published in:
- EJHaem, 2022, v. 3, n. 3, p. 775, doi. 10.1002/jha2.422
- By:
- Publication type:
- Article